• Fresenius Medical Care’s third-quarter 2026 net income fell 42% year over year to EUR 160 million.
• Revenue rose to EUR 4.94 billion, while operating cash flow climbed 8% year over year to EUR 798 million.
• Care Enablement swung to an operating loss of EUR 32 million, mainly due to one-time costs related to its China strategy refinement.
• The 5008X CAREsystem rollout replaced approximately 16% of U.S. clinic dialysis machines, remaining on track for the 2026 target of around 20%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.